Respiratory Flashcards
Short acting Beta 2 agonists
Albuterol
Indications & Pharmacodynamics
Indications: asthma, COPD
Pharmacodynamics: acts on smooth muscle of bronchi to reverse bronchospasm, which decreases airway resistance and residual volume and increases vital capacity and airflow
Short Acting Beta 2 agonists
Albuterol
Caution/contraindications: when to avoid, caution, pregnancy, peds & adverse fx (6)
- Caution/contraindications
- Avoid: arrythmias that cause tachycardia and pheochromocytoma
- Caution: CVD, DM, glaucoma and hyperthyroidism
- Pregnancy: benefits outweigh the risks; Lactation: OK with infant monitoring
- Peds: approved
- Adverse drug effects: tachycardia, dizziness, palpitations, tremors, nervousness, headaches
Long acting beta 2 receptor agonists
Salmeterol
Indications & Pharmacodynamics
Indications: adjunctive therapy for asthma, COPD
Pharmacodynamics: relaxes bronchial smooth muscle by selective action on beta 2 receptors; onset is 30-45 minutes, not for rescue
Long acting beta 2 receptor agonists
Salmeterol
Caution/contraindications: other considerations, caution, pregnancy, peds & adverse fx (6)
- Caution and contraindications
- Other considerations: Use is contraindicated without the use of an asthma controller medication such as inhaled steroid
- Caution:CVD, DM, hyperthyroidism
- Pregnancy: benefits outweigh the risks; Lactation: OK with infant monitoring
- Peds: 4+
- Adverse drug effects: tachycardia, dizziness, palpitations, tremors, nervousness, headache
Which beta 2 agonist is preferred if needed during pregnancy?
Terbutaline
Xanthine derivatives
Theophylline
Indications & Pharmacodynamics
- Indications: asthma, COPD (not first line)
- Pharmacodynamics: inhibits specific phosphodiesterases which in turn increase cAMP, which leads to relaxation of bronchial smooth muscle and pulmonary vessel relaxation; increases force of contraction of diaphragmatic muscles; similar fx as caffeine d/t similar chemical structures
Xanthine derivatives
Theophylline
Caution/contraindications: avoid, pregnancy, peds, caution, monitoring, other considerations
- Avoid: hypersensitivity to xanthine, PUD, seizure disorder
- Pregnancy: Assess with OB risks vs. benefits
- Peds: approved
- Caution: Closely monitor in pts with HTN, ischemic heart disease, coronary insufficiency, CHF or hx of stroke and cardiac arrythmias
- Monitoring: Narrow TI - routine monitoring needed when first starting, adding or removing any other medication
- Other considerations
- Elimination is influenced by diet
- Smoking increases excretion
- Volume of distribution altered in premature neonates, older patients, cirrhosis, pregnant women, critically ill patients
Xanthine derivatives
Theophylline
Adverse fx (including what happens with toxic levels) (16)
- Adverse fx: tachycardia, palpitations, irritability, gastric irritation, HA
- Toxicity (levels greater than 20mcg/mL): nausea, vomiting, diarrhea, headache, insomnia, irritability
- Toxicity (greater than 35): hypotension, cardiac arrythmias, seizures, brain damage, death
Short acting anticholinergics
Ipratropium bromide (atrovent)
Indications & Pharmacodynamics
- Indications: asthma exacerbation (with albuterol), COPD
- Pharmacodynamics: blocks action of acetylcholine at the muscarinic cholinergic receptors in bronchial smooth muscle causing bronchodilation; onset within 15 min
- Reduces the volume of sputum without changing the viscosity
Short acting anticholinergics
Ipratropium bromide (atrovent)
Caution/contraindications: avoid, pregnancy, peds & adverse fx (6)
- Avoid: urinary retention, BPH, closed-angle glaucoma
- Pregnancy: use if only clearly indicated; lactation: compatible
- Peds: Approved
- Adverse fx: cough, dry mouth, mouth and throat irritation, dyspepsia, nausea, vomiting
Long-acting anticholinergics
Tiotropium bromide (Spiriva)
Indications & Pharmacodynamics
Indications: asthma, COPD
Pharmacodynamics: inhibits muscarinic M3 receptors in the lungs leading to smooth muscle bronchodilation
Long-acting anticholinergics
Tiotropium bromide (Spiriva)
Caution/contraindications avoid, other considerations, pregnancy, peds & adverse fx (5)
- Avoid: urinary retention, BPH, closed-angle glaucoma
- Other considerations: Not for asthma exacerbation
- Pregnancy: only if clearly indicated; lactation: approved
- Peds: 6+
- Adverse fx: dry mouth, pharyngitis, URI, HA, mouth irritation
Leukotriene modifiers
Montelukast
Indications & Pharmacodynamics
Indications: chronic asthma, allergic rhinitis
Pharmacodynamics: inhibits cysteinyl leukotriene receptor which is correlated with the patho of asthma, including airway edema and smooth muscle contraction
Leukotriene modifiers
Montelukast & Zafirlukast
Caution/contraindications (Zafirlukast: avoid, caution, peds; Montelukast: avoid, peds); both pregnancy & adverse fx (4)
- Zafirlukast
- avoid: active liver disease
- caution: dose reduction in hepatic dysfunction
- Peds 5+ ok
- Montelukast
- avoid: severe liver disease
- peds: persistent asthma 12+ months, exercise-induced asthma 15+ years
- Pregnancy: approved; lactation: caution
- Adverse fx: headache, GI upset, myalgias, increase in respiratory infections
Leukotriene Modifiers
Zileuton
Indications & Pharmacodynamics
Indications: chronic asthma
Pharmacodynamics: inhibits 5-lipoxygenase from arachidonic acid - results in reduction of inflammation, edema, mucous secretion and bronchoconstriction